Cargando…

Self-Reported Risks for Multiple-Drug Resistance among New Tuberculosis Cases: Implications for Drug Susceptibility Screening and Treatment

BACKGROUND: Multiple drug-resistance in new tuberculosis (TB) cases accounts for the majority of all multiple drug-resistant TB (MDR-TB) worldwide. Effective control requires determining which new TB patients should be tested for MDR disease, yet the effectiveness of global screening recommendations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brewer, Timothy F., Choi, Howard W., Seas, Carlos, Krapp, Fiorella, Zamudio, Carlos, Shah, Lena, Ciampi, Antonio, Heymann, S. Jody, Gotuzzo, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194818/ https://www.ncbi.nlm.nih.gov/pubmed/22022459 http://dx.doi.org/10.1371/journal.pone.0025861

Ejemplares similares

Public Transportation and Tuberculosis Transmission in a High Incidence Setting
por: Zamudio, Carlos, et al.
Publicado: (2015)

High Prevalence of Primary Multidrug Resistant Tuberculosis in Persons with No Known Risk Factors
por: Otero, Larissa, et al.
Publicado: (2011)

Implementation of a stepped-wedge cluster randomized design in routine public health practice: design and application for a tuberculosis (TB) household contact study in a high burden area of Lima, Peru
por: Shah, Lena, et al.
Publicado: (2015)

A prospective longitudinal study of tuberculosis among household contacts of smear-positive tuberculosis cases in Lima, Peru
por: Otero, Larissa, et al.
Publicado: (2016)

Clinical Prediction Rule for Stratifying Risk of Pulmonary Multidrug-Resistant Tuberculosis
por: Martínez, Dalila, et al.
Publicado: (2010)

A Diagnostic Accuracy Study of Xpert®MTB/RIF in HIV-Positive Patients with High Clinical Suspicion of Pulmonary Tuberculosis in Lima, Peru
por: Carriquiry, Gabriela, et al.
Publicado: (2012)

Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru
por: Schwalb, Alvaro, et al.
Publicado: (2021)

Chronic, Progressive Back Pain, Fever and a Noticeable Paravertebral Mass
por: Villaverde, Homarh, et al.
Publicado: (2011)

Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin- Mono-Resistant Pulmonary Tuberculosis in Lima, Peru
por: Villegas, Leonela, et al.
Publicado: (2016)

HIV screening among newly diagnosed TB patients: a cross sectional study in Lima, Peru
por: Ramírez, Suzanne, et al.
Publicado: (2018)

Association of Major Depressive Episode with Negative Outcomes of Tuberculosis Treatment
por: Ugarte-Gil, Cesar, et al.
Publicado: (2013)

Knowledge about HIV prevention and transmission among recently diagnosed tuberculosis patients: a cross sectional study
por: Ugarte-Gil, Cesar, et al.
Publicado: (2013)

Mycobacterium tuberculosis-specific cytokine biomarkers for the diagnosis of childhood TB in a TB-endemic setting
por: Sudbury, Eva L., et al.
Publicado: (2019)

Treatment of Drug Susceptible Pulmonary Tuberculosis
por: Shin, Hong-Joon, et al.
Publicado: (2015)

High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant Mycobacterium tuberculosis isolates
por: Trisakul, Kanwara, et al.
Publicado: (2022)

The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Miller, William R, et al.
Publicado: (2018)

Unsuspected and extensive transmission of a drug-susceptible Mycobacterium tuberculosis strain
por: López-Calleja, Ana Isabel, et al.
Publicado: (2009)

Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug Resistance
por: Kirwan, Daniela E., et al.
Publicado: (2016)

Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial
por: Demers, Anne-Marie, et al.
Publicado: (2021)

The mutational signatures of poor treatment outcomes on the drug-susceptible Mycobacterium tuberculosis genome
por: Chen, Yiwang, et al.
Publicado: (2023)

Case Report of an Extensively Drug-Resistant Klebsiella pneumoniae Infection With Genomic Characterization of the Strain and Review of Similar Cases in the United States
por: Krapp, Fiorella, et al.
Publicado: (2018)

Quantitative Drug-Susceptibility in Patients Treated for Multidrug-Resistant Tuberculosis in Bangladesh: Implications for Regimen Choice
por: Heysell, Scott K., et al.
Publicado: (2015)

Molecular drug susceptibility testing and strain typing of tuberculosis by DNA hybridization
por: Wood, Hillary N., et al.
Publicado: (2019)

Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs
por: Sanchotene, Karine O., et al.
Publicado: (2008)

Epidemiology of tuberculosis and susceptibility to antituberculosis drugs in Reunion Island
por: Loukman, Moreea, et al.
Publicado: (2023)

Clinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis
por: Kwon, Yong-Soo
Publicado: (2017)

Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe
por: Makamure, Beauty, et al.
Publicado: (2013)

Use of Drug-Susceptibility Testing for Management of Drug-Resistant Tuberculosis, Thailand, 2004–2008
por: Lam, Eugene, et al.
Publicado: (2014)

Clinical Implications of Antifungal Drug Susceptibility Testing of Dermatophytes
por: Khurana, Ananta, et al.
Publicado: (2019)

Spread of Extensively Drug-resistant Tuberculosis
por: Samper, Sofía, et al.
Publicado: (2007)

Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs
por: Sharaf Eldin, Ghada S, et al.
Publicado: (2011)

Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis
por: Nahid, Payam, et al.
Publicado: (2011)

Tuberculosis therapy in Mumbai: Critical importance of drug-susceptibility testing
por: Daftary, Amrita, et al.
Publicado: (2016)

Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs
por: Farooq, Hamzah Z., et al.
Publicado: (2021)

Preventive Treatment for Household Contacts of Drug-Susceptible Tuberculosis Patients
por: Salazar-Austin, Nicole, et al.
Publicado: (2022)

Promise and Peril of Pretomanid–Rifamycin Regimens for Drug-susceptible Tuberculosis
por: Velásquez, Gustavo E., et al.
Publicado: (2023)

Drug Resistance Mechanisms in Mycobacterium tuberculosis
por: Palomino, Juan Carlos, et al.
Publicado: (2014)

Mixed infections in genotypic drug-resistant Mycobacterium tuberculosis
por: Wang, Linfeng, et al.
Publicado: (2023)

First Susceptibility Testing of Mycobacterium tuberculosis for Second-line Anti-tuberculosis Drugs in Ghana
por: Kato, Tomoko, et al.
Publicado: (2014)

Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia
por: Lisdawati, Vivi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3db4glm84dha6osrqu61o1vjp1